656 related articles for article (PubMed ID: 21411626)
1. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition.
Gregory PA; Bracken CP; Smith E; Bert AG; Wright JA; Roslan S; Morris M; Wyatt L; Farshid G; Lim YY; Lindeman GJ; Shannon MF; Drew PA; Khew-Goodall Y; Goodall GJ
Mol Biol Cell; 2011 May; 22(10):1686-98. PubMed ID: 21411626
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
[TBL] [Abstract][Full Text] [Related]
3. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E
PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743
[TBL] [Abstract][Full Text] [Related]
4. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.
Kolesnikoff N; Attema JL; Roslan S; Bert AG; Schwarz QP; Gregory PA; Goodall GJ
J Biol Chem; 2014 Apr; 289(16):11194-11205. PubMed ID: 24627491
[TBL] [Abstract][Full Text] [Related]
5. Autocrine TGF-β/ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition: Kinetic models predict minimal drug dose to inhibit metastasis.
Rateitschak K; Kaderali L; Wolkenhauer O; Jaster R
Cell Signal; 2016 Aug; 28(8):861-70. PubMed ID: 27000495
[TBL] [Abstract][Full Text] [Related]
6. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.
Hill L; Browne G; Tulchinsky E
Int J Cancer; 2013 Feb; 132(4):745-54. PubMed ID: 22753312
[TBL] [Abstract][Full Text] [Related]
7. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.
Ohashi S; Natsuizaka M; Naganuma S; Kagawa S; Kimura S; Itoh H; Kalman RA; Nakagawa M; Darling DS; Basu D; Gimotty PA; Klein-Szanto AJ; Diehl JA; Herlyn M; Nakagawa H
Cancer Res; 2011 Nov; 71(21):6836-47. PubMed ID: 21890822
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
9. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
Brabletz S; Brabletz T
EMBO Rep; 2010 Sep; 11(9):670-7. PubMed ID: 20706219
[TBL] [Abstract][Full Text] [Related]
10. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
11. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
12. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1.
Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y
Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
14. Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network.
Shen A; Lin W; Chen Y; Liu L; Chen H; Zhuang Q; Lin J; Sferra TJ; Peng J
Int J Oncol; 2015 Feb; 46(2):685-90. PubMed ID: 25422078
[TBL] [Abstract][Full Text] [Related]
15. TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops.
Zhang J; Tian XJ; Zhang H; Teng Y; Li R; Bai F; Elankumaran S; Xing J
Sci Signal; 2014 Sep; 7(345):ra91. PubMed ID: 25270257
[TBL] [Abstract][Full Text] [Related]
16. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
18. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
[TBL] [Abstract][Full Text] [Related]
19. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells.
Sinh ND; Endo K; Miyazawa K; Saitoh M
Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944
[TBL] [Abstract][Full Text] [Related]
20. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]